Nitto Denko Avecia (US) acquires US Girindus America, strengthens oligonucleotide CMO business

Girindus America, Inc., Cincinnati, Ohio, is a recognized company in the therapeutic oligonucleotide manufacturing business serving major pharmaceutical and biotech companies with small- and large-scale manufacturing capabilities. NITTO DENKO Avecia Inc. is a drug development and manufacturing service company located in Milford, MA, and is a part of Nitto Denko Corporation. Avecia is a recognized leader in process development, manufacturing and related services for DNA and RNA-based therapeutics. All services are offered, from pre-clinical testing to post-commercial launch of innovative oligonucleotide-based therapeutics.

Nitto Denko press release, Nov. 13, 2012

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny